free portfolio web templates


VARN News


Sabin Vaccine Institute launching new global network to help immunization programs increase vaccination acceptance and reduce hesitancy


Vaccination Acceptance Research Network (VARN) aims to foster more collaboration between healthcare providers, researchers from a range of disciplines and immunization programs

The Sabin Vaccine Institute (Sabin) is leading an effort to create a new global Vaccination Acceptance Research Network (VARN) to help immunization programs better understand and address vaccination acceptance and hesitancy challenges. As part of its leadership, Sabin is serving as the Executive Secretariat for the network.

“The measles outbreaks that are happening in the United States and in many countries across the globe highlight the need for new approaches to vaccination acceptance,” said Dr. Bruce Gellin, Sabin’s president of global immunization. “The Vaccination Acceptance Research Network will bring experts from multiple disciplines together with immunization programs and providers to do projects that help better understand the barriers to acceptance and to design ways to address the barriers.”

Along with measles outbreaks, a recent World Health Organization report that identified vaccination hesitancy as one of the top ten threats to global health, shows the need for a network that can bring together a broad array of expertise to assist immunization programs and providers. According to Gellin, the VARN network will link immunization program professionals and researchers from academic and university-based schools and programs, international and other advocacy organizations, public health organizations, national public health institutes, and the International Association of Immunization Managers, which is part of Sabin’s broader efforts.

For more information, e-mail: varn@sabin.org or sign-up


Weekly News Articles

Recent Open Access Journal Articles

Criteria for Article Selection: Global representation, Open Access, Balance between formative and intervention research, relatively recent –within past year

ICVA